Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05438914
Other study ID # AIRR-00608-20
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date November 14, 2022
Est. completion date September 14, 2025

Study information

Verified date January 2024
Source Arthrex, Inc.
Contact Kelly A Ganz
Phone 1 (800) 933-7001
Email kelly.ganz@arthrex.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will evaluate the subscapularis repair versus non-repair during a reverse shoulder arthroplasty (RSA).


Description:

The primary objective of this study is to evaluate pain and function in patients undergoing RSA with or without subscapularis repair. This primary outcome will be measured by analysis of Constant scores at two years post-operative. Secondary objectives are to evaluate pain, function and imaging, between the two groups at each applicable time point.


Recruitment information / eligibility

Status Recruiting
Enrollment 134
Est. completion date September 14, 2025
Est. primary completion date September 14, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years to 100 Years
Eligibility Inclusion Criteria: 1. Patient is scheduled to undergo a reverse shoulder arthroplasty procedure using the Arthrex ReversTM system. 2. Patient voluntarily consents to participate in the study and has the mental and physical ability to participate in the study, fill out subjective questionnaires, return for follow-up visits, and comply with prescribed post-operative physical therapy. 3. Patient meets FDA cleared indications for reverse shoulder arthroplasty 4. Patient is between 18-100 years old 5. Patient agrees to also be enrolled in the Arthrex Total Shoulder Registry Study 6. Patient has a standard of care pre-operative CT taken within 6 months that has been submitted for Arthrex Virtual Implant Positioning TM (VIP) planning Exclusion Criteria: 1. Patient has a history of ipsilateral shoulder arthroplasty 2. A history of shoulder septic arthritis 3. A full thickness subscapularis tear 4. An acute or malunited proximal humeral fracture 5. Chronic locked dislocation 6. Rheumatoid arthritis 7. Tumors 8. Axillary nerve damage 9. Non-functioning deltoid muscle 10. Glenoid vault deficiency precluding baseplate fixation 11. Infection and neuropathic joints 12. Known or suspected non-compliance, drug or alcohol abuse 13. Patients incapable of judgement or under tutelage 14. Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, contraindication for imaging etc. 15. The subject is related to investigator as family members, employees, or other dependent persons 16. Any prior open anterior shoulder surgery that included takedown of the subscapularis tendon or violation of the subscapularis tendon (i.e. Latarjet, Bristow)

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Repair of the subscapularis
The subscapularis will be repaired using the "suture through bone and prosthesis holes" surgical technique.

Locations

Country Name City State
United States The Campbell Clinic Collierville Tennessee
United States Western Orthopaedics, P.C. Denver Colorado
United States The Hawkins Foundation Greenville South Carolina
United States Southern Oregon Orthopedics Medford Oregon
United States Jordan Young Institute Norfolk Virginia
United States The University of Arizona/Banner Health Phoenix Arizona

Sponsors (1)

Lead Sponsor Collaborator
Arthrex, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Constant-Murley Shoulder Outcome Score A combination of objective measures and patient-reported outcomes. It defines the level of pain and the ability to carry out the normal daily activities of the patient. It is a 0-100 point scale, the higher the score, the higher the quality of the function. Collected at at pre-op, but the primary outcome is the score at 2 years post-procedure.
Primary Constant-Murley Shoulder Outcome Score A combination of objective measures and patient-reported outcomes. It defines the level of pain and the ability to carry out the normal daily activities of the patient. It is a 0-100 point scale, the higher the score, the higher the quality of the function. Collected at at 9 week post-op timepoint, but the primary outcome is the score at 2 years post-procedure.
Primary Constant-Murley Shoulder Outcome Score A combination of objective measures and patient-reported outcomes. It defines the level of pain and the ability to carry out the normal daily activities of the patient. It is a 0-100 point scale, the higher the score, the higher the quality of the function. Collected at at the 26 week post-op timepoint, but the primary outcome is the score at 2 years post-procedure.
Primary Constant-Murley Shoulder Outcome Score A combination of objective measures and patient-reported outcomes. It defines the level of pain and the ability to carry out the normal daily activities of the patient. It is a 0-100 point scale, the higher the score, the higher the quality of the function. Collected at at 1 year post-op timepoint, but the primary outcome is the score at 2 years post-procedure.
Primary Constant-Murley Shoulder Outcome Score A combination of objective measures and patient-reported outcomes. It defines the level of pain and the ability to carry out the normal daily activities of the patient. It is a 0-100 point scale, the higher the score, the higher the quality of the function. Collected at the 2 year post-op timepoint, and is the primary outcome measure
Secondary Ultrasound Evaluation of the subscapularis complex in patients that have been randomized to "repair of the subscapularis" to examine the subscapularis complex. Ultrasound scans will be read and the integrity of the subscapularis complex will be determined by the clinician to be "intact", "attenuated", "partial tear" or "complete tear". Collected once at either the 6 month, 1 year or 2 year timepoint.
Secondary American Shoulder and Elbow Surgeons (ASES) subjective survey A combination of objective measures and patient-reported outcomes, it measures pain and functional limitations in the shoulder. The objective questionnaire allows documentation of range of motion in the patient. Collected at pre-op, 9 weeks, 26 weeks, 1 year and 2 year post-op timepoints.
Secondary Simple Shoulder Test (SST) questionnaire Provides a standardized way of recording the function of a shoulder before and after treatment. Collected at pre-op, 9 weeks, 26 weeks, 1 year and 2 year post-op timepoints.
Secondary Visual Analog Scale (VAS) The standard measure for pain on a 0-10 scale, 10 being the worst. Collected at pre-op, 9 weeks, 26 weeks, 1 year and 2 year post-op timepoints.
Secondary Western Ontario Osteoarthritis of the Shoulder Index (WOOS) A patient administrated questionnaire for measurement of the quality of life. It provides scores on four domains: 1.) physical symptoms, 2.) sport, recreation, and work, 3.) lifestyle and 4.) emotions. Collected at pre-op, 9 weeks, 26 weeks, 1 year and 2 year post-op timepoints.
Secondary Veterans Rand 12 Item Health Survey (VR-12) A self-administered health measure. Answers are summarized into two scores, a Physical Component Score and a Mental Component Score, which provides an important contrast between the respondents' physical and psychological health status. Collected at pre-op, 9 weeks, 26 weeks, 1 year and 2 year post-op timepoints.
Secondary Single Assessment Numeric Evaluation score (SANE) Asks patients to rate shoulder pain as a percentage of normal. Collected at pre-op, 9 weeks, 26 weeks, 1 year and 2 year post-op timepoints.
Secondary Standard Pre-Operative Form A patient administered form that asks patients to evaluate their expectations of their scheduled Arthroplasty procedure. Collected at the pre-op visit.
Secondary Return to Work Form A patient administered form that asks patients to determine the effect that their shoulder has had on their employment. Collected at pre-op, 26 weeks and 1 year.
Secondary Standard Late Postoperative Form A patient administered form that asks patient to evaluate if their expectations were met regarding their Arthroplasty procedure. Collected at the 1 year and 2 year timepoints.
See also
  Status Clinical Trial Phase
Active, not recruiting NCT06105398 - the Effect of Core Stability on Hand Functions
Completed NCT01778777 - Safety Study of Univers® Revers Shoulder Prosthesis N/A
Recruiting NCT05002335 - Clinical and Radiological Outcomes of Medacta Shoulder System (BE)
Active, not recruiting NCT02588027 - Effect of Ibuprofen on Postoperative Opiate Medication Use and Shoulder N/A
Withdrawn NCT01873651 - Longterm Outcome of the Delta III Inverse Prosthesis Phase 4
Not yet recruiting NCT04093804 - Impact of Glenosphere Size on Range of Motion in Female Patients Undergoing Reverse Shoulder Arthroplasty N/A
Recruiting NCT04529798 - Clinical Study Evaluating Outcomes of Reverse Shoulder Arthroplasty With SMR Stemless
Completed NCT01954433 - Costs and Consequences of Three Common Orthopedic Procedures on the Upper Extremity
Withdrawn NCT03488433 - Abduction Brace Versus Antirotation Sling for Immobilization Following Reverse Shoulder Arthroplasty and Rotator Cuff Repair N/A
Not yet recruiting NCT06292169 - Pectoralis Minor Release Versus Non-release in RSA N/A
Not yet recruiting NCT05355844 - Cutibacterium Acnes in Deep Tissues in Primary Spine and Shoulder Surgery N/A
Completed NCT01687894 - Vasopressin to Prevent Hypotension During Beach Chair Surgery N/A
Enrolling by invitation NCT01405781 - Functional and Radiographic Outcomes After Shoulder Surgery
Completed NCT03111147 - Impact of Humeral Component Version on Outcomes Following RTSA N/A
Active, not recruiting NCT03425500 - Massive Rotator Cuff Tear Reconstruction N/A
Active, not recruiting NCT02679352 - SMR Stemless Shoulder Arthroplasty Clinical Study N/A
Recruiting NCT05926622 - Clinical and Radiological Outcomes of Medacta Shoulder System FR
Recruiting NCT03547947 - Clinical and Radiological Outcomes of Medacta Shoulder System
Withdrawn NCT04285606 - Effect of Postop Rehab Methods on Outcomes Following Reverse Shoulder Arthroplasty N/A
Completed NCT02512536 - Does Botulinum A Toxin Help With Pain From Rotator Cuff Arthropathy? Phase 2